Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Unless something has changed i do not think much will be happening with allergens. As per the response i received in June of last year. Below is a copy of the e-mail together with other questions i raised at that time.
Wed 10/06/2020 05:09
I will try to answer as many questions as I am permitted to – see below
Sent: 09 June 2020 17:54
Subject: Re: Returning to normal
I just have a couple of follow on questions re todays update
In terms of Moligic do you anticipate sales during the next quarter together with further sales from China re food tec – As we announced yesterday we have received our first sale for the Mologic test and with on-going activities in 15 countries then I think it would be fair to assume that we expect further sales in the next quarter. Similarly with China as we have announced we made shipments last FY and these will continue during this FY. The question is more the size of the forward orders, which will be driven when our partner receives the self-test approval and how quick they can then convert that to demand. They do however have demand for the lab test already.
Also how quickly would you envisage sales for poc re rtc after design freeze
Once design freeze is reached Abingdon will then complete the V&V activities and once that is complete we will tech transfer to the alva site. This I am afraid is price sensitive information and not something we have disclosed to date. We want to reach design freeze then provide appropriate update
Also are things still on track for who validation of cd4 advanced. – we are pleased with the progress to date with WHO pre-qual, but we are not in control of those timelines.
Sorry one more. Has allergens just been mothballed .Meaning they could be continued at a future date.
I think its highly unlikely that we would restart the development of the remaining allergens. We are committed to continue to supply the 69 allergens we have already CE marked. I also believe that we have better opportunities in the short and mid term with lateral flow products that will drive our revenue growth at a faster rate.
Due to the nature of the above questions I would fully understand if you cannot answer all of them.
We are on the cusp of great things with this company, how the fe ck are we still under £1 the mind boggles.
Another expansion is going to be needed at this rate :-)
CAGR of 9.5% is nothing to be sniffed at. Laughably they spelled ThermoFisher incorrectly though. Only the most monstrous company in all biological science.
https://ksusentinel.com/2021/03/08/allergy-diagnostics-market-to-register-stunning-growth-players-omega-diagnostics-siemens-healthineers-stallergenes-thermo-fischer-scientific/
Excellent article from today illustrating the size of the allergy diagnostics market poised to reach $6.4 bn in value from 2020-2027.
Look at some of the companies we are named alongside...
Strong and steady climb today. Let’s keep this going until news lands.